I.V. Iron (Intravenous) Drugs Market 2016 Edition: Key Major Players Are Galenica Group, AMAG Pharmaceuticals & Allergan
The global I.V. iron drugs market is growing rapidly due to improvement in the quality of treatment outside dialysis, increasing number of dialysis patients, growing number of ERSD patients worldwide and growing ageing population. Moreover, increasing cases of hypertension, rising healthcare expenditure, prevalence of iron deficiency in women, large potential in new therapeutic areas and higher spending on medicine are also supporting the growth of I.V. iron drugs market. Complete report available at www.marketreportsonline.com/481407.html. The US and Europe represents key...
View full press release